GPT and COVID-19: Recent studies on COVID-19 have shown that the incidence of liver injury affected around 14.8%-53% of cases, indicated by an abnormal ALT/AST levels accompanied by slightly elevated bilirubin levels.8 In our study, 75% of the COVID-19 infected patients presented abnormal liver function, which was slightly higher than other reports.